Connect with us

Technology

XP Health continues fast growth trajectory with $33.2 million infusion of capital

Published

on

Series B funding demonstrates growing interest in vision programs and vision care among investors and employers

SAN CARLOS, Calif., Sept. 13, 2024 /PRNewswire/ — XP Health, a company dedicated to modernizing vision care with a digital-first vision care platform, announced today a new $33.2 million Series B infusion of capital.

XP Health continues fast growth trajectory with $33.2 million infusion of capital for its digital-first vision care platform

This round of funding was led by global fintech VC firm QED Investors with other prominent investors including Canvas Ventures, American Family Ventures, HC9 Ventures, Valor Capital Group, and Manchester Story, who were all also part of a $17.1 million Series A round announced in fall 2022.

XP Health has raised a total of more than $55 million. The company offers full replacement vision programs that help reduce employee out of pocket cost, while providing a fresh approach to the vision care experience. Its vision programs cover more than 250,000 people and have seen rapid growth in the last two years since launching its platform, expanding from 30 to over 3000 business customers, including DocuSign, Navistar, Chegg, Sequoia Consulting, and strategic partners like The Guardian Life Insurance Company of America.

“Vision care is an indispensable provision for employee wellbeing, and we are excited to partner with XP Health on building a category leader,” said Victoria Zuo, of QED Investors. “Employees are tired of overpaying for out of pocket costs for vision care. With XP Health, they can now dramatically decrease that expense while enjoying a far superior user experience and product.”

QED Investors’ portfolio has encompassed 225 investments across 19 countries, including 28 unicorns such as Credit Karma, Nubank, Remitly, Flywire, and SoFi, as well as health and benefits companies like Decent, Finch, and EasyHealth.

“We’re proud to raise a substantial round with great terms, despite the tough funding environment, which demonstrates our continued growth and a strong demand from employers and benefit partners for a modern vision care solution,” said Antonio Moraes, CEO and co-founder of XP Health. “With this new investment, we’ll strengthen our competitive advantage by focusing on a best-in-class customer experience that includes reducing traditional employee vision costs by as much as 69 percent, and expanding our production capacity to eventually serve 10 million members.”

According to Moraes, XP Health will invest in R&D to continue expanding its product offering, as well as increase its focus on Generative AI products that will improve the member experience and continue to reduce typical member friction points in vision care, such as reducing the time it takes for appointment scheduling and enhancing the digital shopping experience. In addition, XP Health will deploy the funding to continue expanding its sales and marketing efforts, further empowering employers and distribution partners nationwide.

About QED Investors
QED Investors is a global leading venture capital firm based in Alexandria, Va. Founded by Nigel Morris and Frank Rotman in 2007, QED Investors is focused on investing in disruptive financial services companies worldwide. QED Investors is dedicated to building great businesses and uses a unique, hands-on approach that leverages its partners’ decades of entrepreneurial and operational experience, helping companies achieve breakthrough growth. Notable investments include AvidXchange, Betterfly, Bitso, Caribou, ClearScore, Current, Creditas, Credit Karma, Flywire, Kavak, Klarna, Konfio, Loft, Mission Lane, Nubank, QuintoAndar, Remitly, SoFi, Wagestream and Wayflyer.

About XP Health
XP Health democratizes access to high-quality, delightful experiences in vision care that double coverage and reduce costs. It is a digital-first vision platform focused on eye exams and eyewear that uses customer-centric design and technology to create a better member experience and improve access. XP Health was founded to combat the often confusing, expensive, and frustrating experiences common with vision care and vision insurance. XP Health was named to Fast Company’s 2021 list of “The World’s Most Innovative Companies,” and over the past year has expanded from 30 to 3000+ customers, including DocuSign, Navistar, Chegg, Sequoia Consulting, and strategic partner Guardian Life Insurance. To learn more visit xphealth.co.

Media Contact

Ivy Cohen
Ivy Cohen Corporate Communications
(212) 399-0026
ivy@ivycohen.com 

View original content:https://www.prnewswire.com/news-releases/xp-health-continues-fast-growth-trajectory-with-33-2-million-infusion-of-capital-302247066.html

SOURCE XP Health

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

48-Hour Saudi Visa Processing, Major Discounts and Unmissable Giveaways – Only at ‘Spectacular Saudi’ in Mumbai

Published

on

By

NEW DELHI, Sept. 21, 2024 /PRNewswire/ — Saudi’s national tourism brand, ‘Saudi Welcome to Arabia’ is hosting its first-ever immersive consumer event ‘Spectacular Saudi’, from September 25 to October 2,  from 2:00 p.m. – 10:30 p.m. at R2 Ground in BKC, Mumbai.

Slated to transport visitors straight to the Heart of Arabia; the 8-day immersive experience will give visitors a glimpse into Saudi’s many wonders and iconic experiences – all while extending the warm Saudi welcome. To give consumers a truly memorable experience Saudi is offering exclusive giveaways and discounts specially curated for Indian travellers.

What’s more, Indian travellers can fast-track their Saudi visas exclusively at the event. All you need is a valid Visa or Mastercard credit card! Head on over to one of eight dedicated Tasheer kiosks, ensure the name on the credit card matches the passport, and have sufficient funds available on the card. After that, sit back and relax as your visa will be in hand within 48 hours!

It has never been easier to visit Saudi. With the most seamless visa process offered to date, the excitement doesn’t end there. On the travel front, SAUDIA Airlines is offering special deals, including a buy one get 50% off on the second ticket if travelling business class. Additionally, all economy class tickets will be 15% off. Attendees will also have the chance to participate in daily giveaways for free flight tickets for two to Saudi. With over 50+ travel trade offers, visitors can access incredible cashback and discounts on Saudi travel packages. Additionally, those booking Saudi packages will enjoy complimentary cultural city tours. Group tour packages to Riyadh, Jeddah, and Dammam will be available exclusively at the event, starting at INR 99,999 for 5 nights.

Visitors can expect unique immersive experiences–including exhibits, culinary delights, Ardah dancers, Saudi coffee, traditional scents, and fashion–all under one roof. So don’t miss out and register here to experience a piece of Saudi, right in the heart of Mumbai.

Photo – https://mma.prnewswire.com/media/2511104/Spectacular_Saudi.jpg

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/48-hour-saudi-visa-processing-major-discounts-and-unmissable-giveaways–only-at-spectacular-saudi-in-mumbai-302254776.html

Continue Reading

Technology

Indian Cancer Genome Atlas Launches the Country’s First Comprehensive Cancer Multi-Omics Data Portal

Published

on

By

Offers open access to cancer data for research

NEW DELHI, Sept. 21, 2024 /PRNewswire/ — The Indian Cancer Genome Atlas (ICGA) has launched India’s first comprehensive cancer multi-omics data portal. This pioneering platform provides open access to clinically correlated data from Indian cancer patients, aimed at transforming cancer research and treatment for Indian populations.

Historically, cancer treatments in India have been based on Western data sets. However, cancers in Indian patients can differ significantly at the molecular level. ICGA’s mission is to create Indian-specific datasets to help researchers and clinicians develop personalized treatment protocols. This new open-access portal represents a monumental step in revolutionizing cancer research, specifically for Indian patients.

The ICGA cancer multi-omics portal is the first in India to offer data that includes DNA, RNA, and protein profiles of breast cancer patients, integrated with clinical outcomes. Currently, the platform consists of data from 50 breast cancer patients, with plans to expand to over 500 patients in the coming year. This data is freely accessible to the global research community under India’s PRIDE guidelines, which promote ethical sharing and collaboration in cancer research.

Key Highlights of this portal include:

India’s First Cancer Multi-Omics Data Portal: A comprehensive resource that offers detailed multi-omics data for breast cancer patients, including genomic and proteomic information.Based on cBioPortal Platform: Derived from the internationally recognized cBioPortal, this platform ensures seamless integration with global cancer research efforts.Initial Dataset from 50 Indian Patients: Provides clinically annotated DNA, RNA, and protein profiles, along with treatment histories and patient outcomes, with an aim to scale up to 500 in a year.Free Access Under PRIDE Guidelines: Adhering to responsible and ethical data-sharing practices, the portal is freely accessible to the scientific community.A Step Toward Precision Oncology for Indian Patients: This initiative is designed to enable the development of personalized cancer treatments tailored to Indian patients.Call for Collaboration:  ICGA invites researchers worldwide to contribute and expand the platform, fostering global collaboration in cancer research.

Professor Shekhar C. Mande, Former DG-CSIR, Currently Senior Professor at Savitribai Phule Pune University
“Making this invaluable cancer data publicly accessible marks a pivotal step in accelerating scientific discoveries and enhancing patient outcomes. By openly sharing this data, we are empowering researchers, clinicians, and innovators to collaborate, explore new frontiers, and drive transformative breakthroughs in cancer treatment.”

Joint Statement from Dr JC Zenklusen – Director of The Cancer Genome Atlas (TCGA) at the NCI, NIH, USA, and Prof Sunil Badve – Vice Chair, Pathology Cancer Programs, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
“Fifteen years ago, when we launched TCGA, we could not have foreseen the remarkable progress cancer research would make. It is incredibly exciting to see ICGA advancing so rapidly and taking bold steps in revolutionizing cancer research. Understanding the genome of cancer patients will improve the treatment of Indians not only in India but also worldwide. We, both, encourage others with similar data to actively contribute to ICGA, so this initiative can grow even faster and drive greater breakthroughs.”

Dr. Anand Deshpande, Chairman and Managing Director at Persistent, and Non-Executive Director at ICGA
“We have made an excellent start with this groundbreaking multi-omics cancer portal. Cancer touches all of us, and the need for more effective, personalized treatments—especially tailored to the unique genetic and environmental factors in India—is urgent. This portal will empower researchers with crucial data to advance customized cancer research for better treatment outcomes. I encourage everyone to contribute and support this vital cause, helping us accelerate progress in the fight against cancer.”

About Indian Cancer Genome Atlas (ICGA):
The Indian Cancer Genome Atlas (ICGA) is a national initiative focused on mapping the genomic, transcriptomic, and proteomic landscapes of cancers across India. As a section 8 not-for-profit organization, the ICGA Foundation, operates through a public-private-philanthropic partnership, with active support from over 50 clinicians, researchers, and data analysts. Its mission is to enhance cancer diagnosis and treatment for Indian patients and contribute to the global understanding of cancer biology. The foundation’s first project focuses on the multi-omics profiling of breast cancer, with plans to extend this effort to other types of cancer in the future.

https://www.icga.in/

View original content:https://www.prnewswire.com/in/news-releases/indian-cancer-genome-atlas-launches-the-countrys-first-comprehensive-cancer-multi-omics-data-portal-302254777.html

Continue Reading

Technology

Huawei Launches All-New Xinghe Intelligent Campus with Full Upgrades, Maximizing Enterprises’ Intelligent Productivity

Published

on

By

SHANGHAI, Sept. 21, 2024 /PRNewswire/ — During HUAWEI CONNECT 2024, the Xinghe Intelligent Campus session was successfully held, attracting more than 200 industry pioneers, experts, and scholars from around the world to explore campus network trends and technological innovations. Also at the event, Huawei unveiled its all-new Xinghe Intelligent Campus Solution that stands out for full upgrades to wireless, application, and operations & maintenance (O&M) experience.

Shawn Zhao, President of the Campus Network Domain, Huawei’s Data Communication Product Line, said, “As video conferencing, AI terminals, and AI applications become more widespread, the campus network access density has increased threefold, and the demand for bandwidth has grown tenfold. In this case, users place new requirements on the assurance for AI applications and audio/video services while expecting more intelligent O&M.”

To meet these needs, Huawei launched its all-new Xinghe Intelligent Campus Solution with full upgrades. Specifically, this solution upgrades wireless experience in performance, roaming, and IoT convergence. It also leverages X-Scheduler (an experience scheduling engine) to upgrade application experience, while drawing on AI-assisted decision-making and a tidal prediction algorithm to upgrade O&M experience. These help customers build an industry-leading digital infrastructure and facilitate the digital and intelligent transformation of enterprises.

In addition, the solution provides end-to-end security assurance. On the wireless side, the innovative Wi-Fi Shield technology radically prevents packet eavesdropping on the air interface. On the wired side, the full-link MACsec capabilities from switches to APs ensure secure campus network data transmission since the very beginning.

Also at the session, leading analyst firms, customers, and partners in various industries shared their unique insights, best practices, and successful cases. Key speakers include Sian Morgan, Research Director of Dell’Oro Group; Dr. Haitham S. Hamsa, Professor of Information Technology, Cairo University; Shang Qun, Assistant to the Director of the Computing Center, Peking University; Sun Pan, Director of Infrastructure Operations Dept, System Digitalization Dept, FAW Group; Connee Zhang, CEO of CypressTel. Their valuable practices will provide a unique reference for the digital and intelligent transformation of enterprises across industries.

Looking ahead, Huawei believes that the Xinghe Intelligent Campus Solution will become the preferred choice for global enterprises’ digital and intelligent transformation to reap more benefits.

For more information about Huawei’s Xinghe Intelligent Campus Solution, visit https://e.huawei.com/en/solutions/enterprise-network/campus-network.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/huawei-launches-all-new-xinghe-intelligent-campus-with-full-upgrades-maximizing-enterprises-intelligent-productivity-302254770.html

SOURCE Huawei

Continue Reading

Trending